Related Experiment Video
Updated: May 14, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
Deficiency of a new protein associated with cardiac syndrome X; called adropin
Ahmet Celik1, Mehmet Balin, Mehmet Ali Kobat
1Department of Cardiology, Elazig Education and Research Hospital, Elazig, Turkey. ahmetcelik39@hotmail.com
Insights
Lower serum adropin levels are linked to cardiac syndrome X (CSX). Adropin is identified as an independent risk factor, suggesting its potential role in CSX pathophysiology and as a diagnostic marker.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Cardiac Syndrome X (CSX) pathophysiology remains unclear, though endothelial dysfunction is common.
- Adropin is known to uniquely regulate endothelial function, making it a potential factor in CSX.
Purpose of the Study:
- To investigate the role of adropin in patients diagnosed with Cardiac Syndrome X.
- To assess the correlation between serum adropin levels and CSX.
Main Methods:
- Compared serum adropin and nitrite/nitrate levels in 86 CSX patients and 86 healthy controls.
- Utilized multiple linear regression and ROC curve analysis to determine risk factors and predictive ability.
Main Results:
- CSX patients had significantly lower serum adropin (1.7 vs. 3.4 ng/mL) and nitrite/nitrate levels (15.9 vs. 25.4 μmol/L).
- Adropin levels positively correlated with nitrite/nitrate levels (r=0.463).
- Adropin, BMI, and nitrite/nitrate levels were independent risk factors for CSX; adropin showed high predictive ability (AUC=0.854, sensitivity=90.7%, specificity=70.9%).
Conclusions:
- Lower serum adropin levels are associated with Cardiac Syndrome X.
- Adropin is an independent risk factor for CSX, highlighting its potential clinical significance.
Abstract:
The pathophysiology of cardiac syndrome X (CSX) is still unclear, but most patients with CSX have endothelial dysfunction. It has been shown that adropin uniquely effects the regulation of endothelial function. The purpose of the study was to evaluate the role of adropin in CSX. Eighty-six consecutive cardiac syndrome X-diagnosed patients and 86 age-sex matched healthy subjects were enrolled into the study. Serum adropin levels, nitrite/nitrate levels were measured in each subject. The adropin levels were significantly lower in patients with CSX than healthy subjects (1.7 ± 0.8 ng/mL and 3.4 ± 1.8 ng/mL, respectively; P < 0.001). The BMI values of patients with CSX were significantly higher than control subjects (28.1 ± 2.4 kg/m(2) and 26.0 ± 3.7 kg/m(2) , respectively; P < 0.001). Plasma nitrite/nitrate levels were lower in patients with CSX than control subjects (15.9 ± 1.6 μmol/L vs. 25.4 ± 2.8 μmol/L, respectively; P < 0.001), and they have a significantly positive correlation with plasma adropin levels (r = 0.463, P < 0.001). In the multiple linear regression analysis, nitrite/nitrate levels, BMI, and adropin were found to be independent risk factors for CSX. A ROC curve is used to identify the ability of adropin levels to predict the cardiac syndrome X. The area under the ROC curve was 0.854 for adropin levels (P = 0.0001). The sensitivity and specificity values of adropin levels were 90.7 and 70.9%, respectively (cut-off value 2.73). In conclusion, lower serum adropin levels were associated with CSX. Adropin is an independent risk factor for CSX.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy

